Sr. Medical Director, Global Medical Affairs, CD38 Immunology Pipeline

Senior Medical Director, Global Medical Affairs, CD38 Pipeline Immunology

About This Role

The Senior Medical Director, Global Medical Affairs – CD38 Pipeline will play a key strategic role within Biogen’s Global Medical organization. Reporting to the Head of Global Medical Nephrology, Transplant and CD38 Pipeline, this individual will lead medical strategy for new, non-nephrology/non transplant indications for the anti-CD38 pipeline for other immune mediated diseases driven by pathogenic antibody production. The role focuses on shaping the medical perspective for pipeline programs by integrating disease‑area expertise, scientific insights, and evolving treatment paradigms to inform development strategy and long‑term asset positioning. The individual will work closely with Research, Clinical Development, and cross‑functional partners to ensure the CD38 pipeline programs are aligned with unmet medical needs and future clinical practice.

What You'll Do

• Lead development of global medical strategies for the CD38 pipeline indications including evidence generation and KME engagement strategy.
• Lead or contribute to the development of indication specific publication strategies and scientific narrative development.
• Partner with Research, Clinical Development and Commercial to shape Target Product Profiles (TPPs) and medical differentiation strategies.
• Maintain a deep understanding of competitive landscapes and evolving standards of care in the pipeline indications.
• Engage with external scientific experts and investigators to inform CD38 pipeline strategy.
• Collaborate across Global Medical Affairs, Clinical Development, and Commercial teams to integrate medical insights and provide sound medical perspectives for cross functional deliverables including market research.
• Support internal governance discussions by synthesizing scientific and clinical information into clear strategic perspectives.

Who You Are

You are a scientifically driven medical leader with strong expertise in immunology, neuroimmunology or endocrinology and the ability to translate complex scientific insights into actionable medical strategy. You work effectively in cross‑functional environments and are comfortable collaborating with research, development, and commercial teams to shape pipeline programs and future clinical positioning. You are a self‑starter who can develop and execute strategies with minimal direction.

Qualifications

• Advanced degree (MD, PhD, PharmD, or equivalent) in a scientific or clinical discipline.
• Minimum of 10+ years of experience in the biopharmaceutical industry.
• At least 5 years of experience supporting pipeline or early‑stage asset strategy.
• Deep scientific expertise in immunology and autoimmune disease biology.
• Ability to synthesize complex scientific and clinical information into strategic medical insights.
• Experience working in cross‑functional environments across research, development, and medical teams.
• Strong communication and presentation skills.

Preferred Skills

• Experience contributing to pipeline portfolio strategy or therapeutic area strategy.
• Familiarity with early asset development (Phase 2+) and clinical trial strategy including Target Product Profiles.
• Strong understanding of competitive landscapes and evolving standards of care in immunology.
• Experience engaging with external scientific experts and academic investigators to gain insights to inform medical strategies.

#LI-SM1 Job Level: Management

Additional Information

The base compensation range for this role is: $278,000.00-$382,000.00 Base salary offered is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity. Regular employees are eligible to receive both short term and long term incentives, including cash bonus and equity incentive opportunities, designed to reward recent achievements and recognize your future potential based on individual, business unit and company performance.

• Medical, Dental, Vision, & Life insurances
• Fitness & Wellness programs including a fitness reimbursement
• Short- and Long-Term Disability insurance
• A minimum of 15 days of paid vacation and an additional end‑of‑year shutdown time off (Dec 26-Dec 31)
• Up to 12 company paid holidays + 3 paid days off for Personal Significance
• 80 hours of sick time per calendar year
• Paid Maternity and Parental Leave benefit
• 401(k) program participation with company matched contributions
• Employee stock purchase plan
• Tuition reimbursement of up to $10,000 per calendar year
• Employee Resource Groups participation

Why Biogen?

We are a global team with a commitment to excellence, and a pioneering spirit. As a mid‑sized biotechnology company, we provide the stability and resources of a well‑established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life‑changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives. At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about Biogen. All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.